Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study
Chronic antigenic stimulation is frequently blamed in the pathogenesis of extranodal marginal zone lymphomas including splenic marginal zone lymphoma (SMZL). Chronic hepatitis C is frequently observed in SMZL patients in some geographical regions. However, these reports are largely from North America and Europe. Data from other countries are insufficient. In this multicenter study we aimed to find out the clinical characteristics of SMZL patients in Turkey, including viral hepatitis status and treatment details. Data were gathered from voluntary centers from different regions of Turkey using an IBM SPSS Statistics for Windows v23 electronic table. One hundred and four patients were reported. Hepatitis C virus positivity was observed in only one patient. However, hepatitis B virus surface antigen (HBsAg) positivity was observed in 11.2% and HBsAg and/or anti-HB core antigen antibody (anti-HBcAg) positivities in 34.2% of the patients. The median age was 60 years (35-87). Median follow-up duration was 21.2 months (0.2-212) (23.2 months for surviving patients). Median OS was not reached. Estimated 3-year and 10-year survival rates were 84.8% and 68.9%, respectively. Older age, no splenectomy during follow-up, <90×103/μl platelet count, lower albumin, higher lactate dehydrogenase, higher β2-microglobulin and HBsAg positivity were associated with increased risk of death. Only albumin remained significant in multivariable analysis. These results indicate that hepatitis B virus may be a possible risk factor for SMZL in our population. It may also be an indirect prognostic factor.